Latest Breaking News On - Haimen jiangsu - Page 1 : comparemela.com

Biocytogen Enters Into Evaluation and Potential Licensing Agreement With BioCopy For TCR-mimic Antibodies

BEIJING, May 06, 2024 Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen", HKEX: 02315), a global biotechnology company focused on the discovery of novel antibody-based therapeutics, today announced a TCR-mimic antibody evaluation and potential licensing agreement with BioCopy AG ("BioCopy"), a research-based biotechnology company headquartered in Basel, Switzerland.

United statesShanghaiChinaSwitzerlandSan franciscoCaliforniaBeijingHeidelbergBaden wübergGermanyHaimen jiangsuYuelei shenBiocytogen pharmaceuticals beijing co ltdBiocytogen pharmaceuticalsAntibody discoveryBiocopy ag

Biocytogen Enters Collaboration with ABL Bio to Develop New Bispecific AntibodyDrug Conjugates

Biocytogen Pharmaceuticals Beijing Co. Ltd. Biocytogen HKEX 02315 a global biotechnology company that drives the research and development of novel antibodybased drugs with innovative technologies and ABL Bio Inc.

United statesShanghaiChinaBeijingSan franciscoCaliforniaHaimen jiangsuHoon leeYuelei shenBiocytogen renliteBiocytogen pharmaceuticals beijing co ltdBio incMedia contact

Biocytogen Enters Collaboration with ABL Bio to Develop New Bispecific Antibody-Drug Conjugates

Biocytogen Enters Collaboration with ABL Bio to Develop New Bispecific Antibody-Drug Conjugates
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSan franciscoCaliforniaShanghaiChinaBeijingBiocytogen renliteHaimen jiangsuYuelei shenHoon leeBio incBiocytogen pharmaceuticals beijing co ltdBiocytogen pharmaceuticals

Biocytogen Pharmaceuticals (Beijing) Co., Ltd.: Biocytogen and Gilead Enter Into a Multi-Target Antibody Collaboration Agreement

Biocytogen Pharmaceuticals (Beijing) Co., Ltd.: Biocytogen and Gilead Enter Into a Multi-Target Antibody Collaboration Agreement
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

ChinaBeijingHeidelbergBaden wübergGermanyUnited statesSan franciscoCaliforniaShanghaiHaimen jiangsuYuelei shenBiocytogen pharmaceuticals beijing co ltdBiocytogen fully human antibody libraryGilead sciences incBiocytogen pharmaceuticalsGilead sciences

Biocytogen and Gilead Enter Into a Multi-Target Antibody Collaboration Agreement

BEIJING, February 19, 2024 Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen", HKEX: 02315) today announces an antibody evaluation and option agreement with Gilead Sciences, Inc. The agreement provides Gilead access to Biocytogen’s extensive fully human antibody library generated against a wide range of therapeutic targets. Over a three-year nomination period, Gilead will nominate targets of interest and evaluate the corresponding antibodies, with the option to acquire selected antibo

ShanghaiChinaUnited statesSan franciscoCaliforniaBeijingHaimen jiangsuYuelei shenGilead sciences incBiocytogen fully human antibody libraryBiocytogen pharmaceuticals beijing co ltdBiocytogen pharmaceuticalsGilead sciencesDrug developmentWileadExtensive library